Identification and validation of key genes associated with pathogenesis and prognosis of gastric cancer
Authors:
Open Access
Abstract
Background: Gastric cancer (GC) is the fourth leading cause of cancer-related death worldwide. However, the precise mechanisms and specific biomarkers of GC have not been fully elucidated. We therefore sought to identify and validate the genes associated with GC. Methods: RNA sequencing was performed on gastric tissue specimens from 10 cases each of non-atrophic gastritis (NAG), intestinal metaplasia (IM), and GC. Validation of gene expression was conducted through immunohistochemistry (IHC) staining. The Kaplan–Meier Plotter database was utilized to screen genes associated with prognosis, while protein–protein interaction analysis was conducted to identify hub genes. Results: In GC-IM, the differentially expressed genes (DEGs) were predominantly enriched in pathways related to ECM-receptor interaction, focal adhesion, PI3K-Akt pathway, and pathways in cancer. Conversely, in IM-NAG, the DEGs were primarily enriched in pathways associated with fat digestion and absorption, pancreatic secretion, and retinol metabolism. IHC staining revealed elevated expression levels of KLK7 and KLK10 in GC. Specifically, KLK7 expression was found to be correlated with differentiation (P = 0.025) and depth of invasion (P = 0.007) in GC, while both KLK7 and KLK10 were associated with the overall survival (P < 0.05). Furthermore, a total of ten hub genes from DEGs in GC-NAG (COL6A2, COL1A1, COL4A1, COL1A2, SPARC, COL4A2, FN1, PCOLCE, SERPINH1, LAMB1) and five hub genes in IM-NAG (SI, DPP4, CLCA1, MEP1A, OLFM4) were demonstrated to have a significant correlation with the prognosis of GC. Conclusions: The present study successfully identified and validated crucial genes associated with GC, providing valuable insights into the underlying mechanisms of this disease. The findings of this study have the potential to inform clinical practice.Keywords
This publication has 48 references indexed in Scilit:
- Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancerWorld Journal of Gastroenterology, 2013
- Gastric intestinal metaplasia revisited: function and regulation of CDX2Trends in Molecular Medicine, 2012
- Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cellsJournal of Biomedical Science, 2012
- Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients’ survivalAnnals of Oncology, 2011
- Downregulation of SPARC expression decreases gastric cancer cellular invasion and survivalJournal of Experimental & Clinical Cancer Research, 2010
- SPARC Is Associated with Gastric Cancer Progression and Poor Survival of PatientsClinical Cancer Research, 2010
- Prostate-specific antigen and prostate cancer: prediction, detection and monitoringNature Reviews Cancer, 2008
- Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancerJournal of Gastroenterology and Hepatology, 2006
- Clinicopathologic and Biological Significance of Kallikrein 6 Overexpression in Human Gastric CancerClinical Cancer Research, 2005
- The emerging roles of human tissue kallikreins in cancerNature Reviews Cancer, 2004